Tessellate BIO has appointed Dr Lara Boyd as Chief Business Officer. Lara joins Tessellate BIO from F-star Therapeutics, an ...

There’s no denying it; pharma is in its innovation era. The life sciences industry is already undergoing a massive revolution ...

Eran Harary, Senior Vice President of Global Early Clinical Development at Teva, said: “This collaboration will provide ...

Osivax, a biopharmaceutical company developing vaccines for broad-spectrum protection against infectious viruses, has ...

The King’s Fund has appointed Siva Anandaciva, its current Chief Analyst, as Director of Policy, Events and Partnerships.

The Department for Science, Innovation and Technology has announced that Dr Daniel Mahony will continue as the UK government’s Life Sciences Investment Envoy. Mahony has more th ...

The Netherlands facility is designed to handle a wide range of nanomedicines, including lipid-based nanoparticles Ardena has announced the full Good Manufacturing Practice (GMP) approval of its ...

AC Immune SA has reported encouraging interim results from its phase 2 VacSYn clinical trial of ACI-7104.056, an anti-alpha-synuclein (a-syn) active immunotherapy for early Parkinson’s disease (PD).

Vivolta, a specialist in medical electrospinning solutions, has entered a long-term partnership with UK-based Neurochase to manufacture electrospun micro-catheters for advanced brain therapies. This ...

First patient dosed in phase 1b trial of MB310 therapy Microbiotica, a clinical-stage biopharma company, has announced the dosing of the first patient in its Phase 1b First-in-Human trial, COMPOSER-1, ...